Literature DB >> 16299285

A leucine-rich motif targets Pseudomonas aeruginosa ExoS within mammalian cells.

Yue Zhang1, Joseph T Barbieri.   

Abstract

Type III cytotoxins contribute to the ability of bacterial pathogens to subvert the host innate immune system. ExoS (453 amino acids) is a bifunctional type III cytotoxin produced by Pseudomonas aeruginosa. Residues 96 to 232 comprise a Rho GTPase activating protein domain, while residues 233 to 453 comprise a 14-3-3-dependent ADP-ribosyltransferase domain. An N-terminal domain (termed the membrane localization domain [MLD]) targets ExoS to the Golgi-endoplasmic reticulum (Golgi-ER) of mammalian cells. This study identifies an amino acid motif that is responsible for the membrane binding properties of the MLD. Deletion mapping showed that the MLD included a symmetrical leucine-rich motif within residues 51 to 77 of ExoS. The terminal dileucines and internal leucines and an isoleucine within the MLD, but not charged or other hydrophobic residues, targeted a reporter protein to the Golgi-ER region of HeLa cells. Mutations of the leucines within the MLD did not affect type III secretion or translocation into HeLa cells but limited the ability of ExoS to ADP-ribosylate Ras GTPases. Mutations of charged residues within the MLD did not affect type III secretion, delivery into HeLa cells, or the ability of ExoS to ADP-ribosylate Ras GTPases. The organization of the leucines within the MLD of ExoS is different from that of previously described leucine-rich motifs but is present in several other bacterial proteins. This implies a role for intracellular targeting in the efficient targeting of mammalian cells by type III cytotoxins.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16299285      PMCID: PMC1307044          DOI: 10.1128/IAI.73.12.7938-7945.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  36 in total

1.  Auto-ADP-ribosylation of Pseudomonas aeruginosa ExoS.

Authors:  Matthew J Riese; Udo-Michael Goehring; Mary E Ehrmantraut; Joel Moss; Joseph T Barbieri; Klaus Aktories; Gudula Schmidt
Journal:  J Biol Chem       Date:  2002-01-30       Impact factor: 5.157

2.  A novel di-leucine motif and a tyrosine-based motif independently mediate lysosomal targeting and endocytosis of CD3 chains.

Authors:  F Letourneur; R D Klausner
Journal:  Cell       Date:  1992-06-26       Impact factor: 41.582

3.  Exocytosis from permeabilized bovine adrenal chromaffin cells is differently modulated by guanosine 5'-[gamma-thio]triphosphate and guanosine 5'-[beta gamma-imido]triphosphate. Evidence for the involvement of various guanine nucleotide-binding proteins.

Authors:  G Ahnert-Hilger; U Wegenhorst; B Stecher; K Spicher; W Rosenthal; M Gratz
Journal:  Biochem J       Date:  1992-06-01       Impact factor: 3.857

4.  Intracellular targeting of the Yersinia YopE cytotoxin in mammalian cells induces actin microfilament disruption.

Authors:  R Rosqvist; A Forsberg; H Wolf-Watz
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

5.  ADP-ribosylation of p21ras and related proteins by Pseudomonas aeruginosa exoenzyme S.

Authors:  J Coburn; D M Gill
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

6.  The yersinia virulence factor YopM forms a novel protein complex with two cellular kinases.

Authors:  Christine McDonald; Panayiotis O Vacratsis; James B Bliska; Jack E Dixon
Journal:  J Biol Chem       Date:  2003-03-06       Impact factor: 5.157

7.  Effect of iron on yields of exotoxin A in cultures of Pseudomonas aeruginosa PA-103.

Authors:  M J Bjorn; B H Iglewski; S K Ives; J C Sadoff; M L Vasil
Journal:  Infect Immun       Date:  1978-03       Impact factor: 3.441

8.  Intracellular membrane localization of pseudomonas ExoS and Yersinia YopE in mammalian cells.

Authors:  Rebecca Krall; Yue Zhang; Joseph T Barbieri
Journal:  J Biol Chem       Date:  2003-11-03       Impact factor: 5.157

9.  Exoenzyme S shows selective ADP-ribosylation and GTPase-activating protein (GAP) activities towards small GTPases in vivo.

Authors:  Maria L Henriksson; Charlotta Sundin; Anna L Jansson; Ake Forsberg; Ruth H Palmer; Bengt Hallberg
Journal:  Biochem J       Date:  2002-11-01       Impact factor: 3.857

Review 10.  Infections caused by Pseudomonas aeruginosa.

Authors:  G P Bodey; R Bolivar; V Fainstein; L Jadeja
Journal:  Rev Infect Dis       Date:  1983 Mar-Apr
View more
  19 in total

1.  Domain analyses reveal that Chlamydia trachomatis CT694 protein belongs to the membrane-localized family of type III effector proteins.

Authors:  Holly D Bullock; Suzanne Hower; Kenneth A Fields
Journal:  J Biol Chem       Date:  2012-06-18       Impact factor: 5.157

Review 2.  From GFP to β-lactamase: advancing intact cell imaging for toxins and effectors.

Authors:  Madison Zuverink; Joseph T Barbieri
Journal:  Pathog Dis       Date:  2015-10-22       Impact factor: 3.166

3.  A protective epitope in type III effector YopE is a major CD8 T cell antigen during primary infection with Yersinia pseudotuberculosis.

Authors:  Yue Zhang; Patricio Mena; Galina Romanov; Jr-Shiuan Lin; Stephen T Smiley; James B Bliska
Journal:  Infect Immun       Date:  2011-11-07       Impact factor: 3.441

4.  A C-terminal domain targets the Pseudomonas aeruginosa cytotoxin ExoU to the plasma membrane of host cells.

Authors:  Shira D P Rabin; Jeffrey L Veesenmeyer; Kathryn T Bieging; Alan R Hauser
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

Review 5.  Toxins from bacteria.

Authors:  James S Henkel; Michael R Baldwin; Joseph T Barbieri
Journal:  EXS       Date:  2010

6.  Expression of Pseudomonas aeruginosa toxin ExoS effectively induces apoptosis in host cells.

Authors:  Jinghua Jia; Yanping Wang; Lei Zhou; Shouguang Jin
Journal:  Infect Immun       Date:  2006-09-11       Impact factor: 3.441

7.  Effector CD8+ T cells are generated in response to an immunodominant epitope in type III effector YopE during primary Yersinia pseudotuberculosis infection.

Authors:  Yue Zhang; Patricio Mena; Galina Romanov; James B Bliska
Journal:  Infect Immun       Date:  2014-05-05       Impact factor: 3.441

8.  Characterization of Pyrin Dephosphorylation and Inflammasome Activation in Macrophages as Triggered by the Yersinia Effectors YopE and YopT.

Authors:  Natasha P Medici; Maheen Rashid; James B Bliska
Journal:  Infect Immun       Date:  2019-02-21       Impact factor: 3.441

Review 9.  Pseudomonas aeruginosa virulence and therapy: evolving translational strategies.

Authors:  Jeffrey L Veesenmeyer; Alan R Hauser; Thiago Lisboa; Jordi Rello
Journal:  Crit Care Med       Date:  2009-05       Impact factor: 7.598

10.  The membrane localization domain is required for intracellular localization and autoregulation of YopE in Yersinia pseudotuberculosis.

Authors:  Elin L Isaksson; Margareta Aili; Anna Fahlgren; Sara E Carlsson; Roland Rosqvist; Hans Wolf-Watz
Journal:  Infect Immun       Date:  2009-08-17       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.